Clinical Trial Update: Trial Evaluating the Efficacy and Safety of Perampanel Added to Monotherapy in Participants With Partial Onset Seizures With or Without Secondary Generalization [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating added-on perampanel to monotherapy in adults with partial onset seizures, completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• Perampanel (perampanel)

Snippet

Sponsor: Eisai Korea Inc. | Conditions: Epilepsy | Phase 4 | Status: COMPLETED | Results posted: 2020-02-05